CONTINUING EDUCATION:
RN, NP:  1 CE Credit, 1 Pharmacology

Recorded Date:  April 15, 2016 (as part of the 2016 PCNA Annual Symposium in Orlando)
Original Posting Date: September 21, 2016
Content Reviewed Date: January 2017

AUDIENCE:
Nurses, advanced practice nurses, and other healthcare providers interested in the prevention and management of cardiovascular disease.

COST:
This online educational activity is offered free of charge.

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.

ACCREDITOR:

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602. 

Please note that if you received credit for attending the 2016 PCNA Annual Symposium in Orlando, you will be unable to claim credit for the on-demand sessions that were recorded there.

List two new drug classes approved in 2015 for the treatment of heart failure
List two specific goals for patient education regarding risk and benefit for these new therapies.
Identify the indications for the use of ivabradine
Identify the indications for the use of the combination agent sacubitril/valsartan in the patient with heart failure